Definitive Proxy Filed for $16.50/Share Take-Private Merger; Shareholder Vote Set for June 26

summarizeSummary

Select Medical Holdings Corp. filed its definitive proxy statement for the take-private merger, setting the shareholder vote for June 26, 2026, on the $16.50 per share all-cash acquisition.

check_boxKey Events

• Shareholder Meeting Scheduled

  A Special Meeting of Stockholders is set for June 26, 2026, to vote on the adoption of the merger agreement. This is a critical step towards finalizing the take-private transaction.

• Merger Terms Finalized

  The definitive merger agreement, signed March 2, 2026, confirms an all-cash acquisition at $16.50 per share. This represents an 18% premium over the unaffected share price of $14.01 on November 24, 2025, and a 42% premium over the 52-week low of $11.65.

• Insider Rollover and Voting Commitment

  Executive Chairman Robert A. Ortenzio and Senior Executive Vice President Martin F. Jackson, along with other Rollover Holders, will contribute their shares to the acquiring entity, collectively owning approximately 21% of the private company post-merger. These insiders have committed to vote their shares in favor of the merger.

• Special Committee Recommendation

  The Special Committee, advised by independent financial and legal advisors, unanimously recommended the merger, concluding that the offer represents the best value reasonably obtainable for unaffiliated shareholders.

auto_awesomeAnalysis

This definitive proxy statement (DEFM14A) provides final details for the upcoming shareholder vote on the previously announced take-private merger. Shareholders will vote on June 26, 2026, to approve the acquisition by a consortium led by Executive Chairman Robert A. Ortenzio for $16.50 per share in cash. The Special Committee unanimously recommended the deal, which offers a significant premium over the unaffected share price and provides immediate liquidity and certainty of value, while insiders will roll over a portion of their equity. The market has largely priced in the deal, with the stock currently trading near the offer price and its 52-week high.